Cipla Ltd vs Vivo Bio Tech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 15, 2026

Key Highlights

The Latest Trading Price of Cipla Ltd is ₹ 1434 as of 15 May 14:27 . The P/E Ratio of Cipla Ltd changed from 27.3 on March 2021 to 22.1 on March 2025 . This represents a CAGR of -4.14% over 5 yearsThe P/E Ratio of Vivo Bio Tech Ltd changed from 11.3 on March 2021 to 8 on March 2025 . This represents a CAGR of -6.67% over 5 years The Market Cap of Cipla Ltd changed from ₹ 65746 crore on March 2021 to ₹ 116434 crore on March 2025 . This represents a CAGR of 12.11% over 5 yearsThe Market Cap of Vivo Bio Tech Ltd changed from ₹ 64.28 crore on March 2021 to ₹ 57.3 crore on March 2025 . This represents a CAGR of -2.27% over 5 years The revenue of Cipla Ltd for the Mar '26 is ₹ 6689 crore as compare to the Dec '25 revenue of ₹ 7280 crore. This represent the decline of -8.12% The revenue of Vivo Bio Tech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 13.65 crore. This represent the decline of -100% The ebitda of Cipla Ltd for the Mar '26 is ₹ 1103 crore as compare to the Dec '25 ebitda of ₹ 1185 crore. This represent the decline of -6.95% The ebitda of Vivo Bio Tech Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 5.63 crore. This represent the decline of -100% The net profit of Cipla Ltd changed from ₹ 1176 crore to ₹ 550.11 crore over 8 quarters. This represents a CAGR of -31.61% The net profit of Vivo Bio Tech Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Cipla Ltd changed from 16.34 % on March 2021 to 25.05 % on March 2025 . This represents a CAGR of 8.92% over 5 yearsThe Dividend Payout of Vivo Bio Tech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Cipla Ltd

Cipla Limited is one of the leading pharmaceutical companies in India.
The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'.

About Vivo Bio Tech Ltd

Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines.
The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies, Genotoxicity screening, Analytical services etc.
Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. The Company stands as a premier and primary provider of SPF lab animals in India.
It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences.

FAQs for the comparison of Cipla Ltd and Vivo Bio Tech Ltd

Which company has a larger market capitalization, Cipla Ltd or Vivo Bio Tech Ltd?

Market cap of Cipla Ltd is 116,211 Cr while Market cap of Vivo Bio Tech Ltd is 61 Cr

What are the key factors driving the stock performance of Cipla Ltd and Vivo Bio Tech Ltd?

The stock performance of Cipla Ltd and Vivo Bio Tech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cipla Ltd and Vivo Bio Tech Ltd?

As of May 15, 2026, the Cipla Ltd stock price is INR ₹1438.65. On the other hand, Vivo Bio Tech Ltd stock price is INR ₹27.82.

How do dividend payouts of Cipla Ltd and Vivo Bio Tech Ltd compare?

To compare the dividend payouts of Cipla Ltd and Vivo Bio Tech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.